MariTide helped participants lose up to 20% of their body weight in a year-long trial. But it could be years before the new ...

Syntis Bio, Inc. (Syntis), a clinical-stage biopharmaceutical company revolutionizing oral therapies for obesity, diabetes ...

A new study from US scientists has predicted a huge increase in this killer cancer-and there's one group in particular at ...

CVS Caremark will stop covering Eli Lilly’s Zepbound. Wegovy, the GLP-1 medication to treat obesity from Lilly competitor ...

Hormonal disorders in children can have significant physical, emotional, and social impacts. These conditions can affect ...

Taking to platforms including Reddit and Telegram for guidance, buyers import small quantities, often described as research ...

Registered dietitian lost 60 pounds with GLP-1 weight loss drug Wegovy. She shares foods to avoid and prioritize to minimize ...

Discover how chronic dieting and calorie restriction sabotage your metabolism, increase hunger hormones, and make weight loss ...

Drug services provider Medtide (3880.HK) is looking to raise HK$514 million (410 million yuan or $65.48 million) in a listing ...

Eli Lilly, Novo Nordisk and Amgen release weight loss drug data as competition heats up in the market, while Abridge announces a $300 million funding round.

Obesity surgery elicits pronounced short-term effects on gut, pituitary, and peripheral hormone pathways in response to a glucose load, unlike a restrictive diet achieving similar weight loss.

1. Estrogen: The metabolic game-changer Estrogen serves as one of the most influential players in the weight management game, particularly for women. This primary female sex hormone doesn’t just ...